Crossmark

Unique ER PR expression pattern in breast cancers with CHEK2 mutation: a hormone receptor and HER2 analysis based on germline cancer predisposition genes

Crossref DOI link: https://doi.org/10.1186/s13058-022-01507-1

Published Online: 2022-02-08

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wei, Grace http://orcid.org/0000-0003-0075-1990
Teng, Mingxiang

Rosa, Marilin

Wang, Xia
Funding

Funding for this research was provided by:

National Cancer Institute (NCI P30CA076292)
License Information

Text and Data Mining valid from 2022-02-08

Version of Record valid from 2022-02-08
More Information

Article History

Received: 14 November 2021

Accepted: 30 January 2022

First Online: 8 February 2022

Declarations

:

: This study was approved by the Moffit Cancer Center Institutional Review Board.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below